Evidence map›Paper›PMID 38696655›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Brain Metastasis from EGFR-Mutated Non-Small Cell Lung Cancer: Secretion of IL11 from Astrocytes Up-Regulates PDL1 and Promotes Immune Escape.

Mengyi Tang, Mingxin Xu, Jian Wang, Ye Liu, Kun Liang, Yinuo Jin, Wenzhe Duan, Shengkai Xia, Guohui Li, Huiying Chu and 2 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Molecular mechanisms and therapeutic targets in lung cancer-nerve crosstalk.Chinese medical journal pulmonary and critical care medicine · 2026
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. CD146Theranostics · 2026
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Mengyi Tangthe Second Affiliated Hospital of Dalian Medical University, 467 Zhongshan Road, Dalian, 116027, China.
Mingxin Xuthe Second Affiliated Hospital of Dalian Medical University, 467 Zhongshan Road, Dalian, 116027, China.
Jian Wangthe Second Affiliated Hospital of Dalian Medical University, 467 Zhongshan Road, Dalian, 116027, China.
Ye LiuLaboratory of Molecular Modeling and Design, State Key Laboratory of Molecular Reaction Dynamics, Dalian Institute of Chemical Physics, Chinese Academy of Science, 457 Zhongshan Road, Dalian, 116023, China.
Kun Liangthe Second Affiliated Hospital of Dalian Medical University, 467 Zhongshan Road, Dalian, 116027, China.
Yinuo Jinthe Second Affiliated Hospital of Dalian Medical University, 467 Zhongshan Road, Dalian, 116027, China.
Wenzhe Duanthe Second Affiliated Hospital of Dalian Medical University, 467 Zhongshan Road, Dalian, 116027, China.
Shengkai Xiathe Second Affiliated Hospital of Dalian Medical University, 467 Zhongshan Road, Dalian, 116027, China.
Guohui LiLaboratory of Molecular Modeling and Design, State Key Laboratory of Molecular Reaction Dynamics, Dalian Institute of Chemical Physics, Chinese Academy of Science, 457 Zhongshan Road, Dalian, 116023, China.
Huiying ChuLaboratory of Molecular Modeling and Design, State Key Laboratory of Molecular Reaction Dynamics, Dalian Institute of Chemical Physics, Chinese Academy of Science, 457 Zhongshan Road, Dalian, 116023, China.
Wenwen Liuthe Second Affiliated Hospital of Dalian Medical University, 467 Zhongshan Road, Dalian, 116027, China.
Qi Wangthe Second Affiliated Hospital of Dalian Medical University, 467 Zhongshan Road, Dalian, 116027, China.ORCID 0000-0003-2427-7234

Funding

Dalian Science and Technology Talent Innovation Support Plan 2022RQ037Liaoning Clinical Medical Research Center Construction ProgramLiaoning Revitalization Talents Program XLYC2002013National Key R&D Program of China 2019YFA0709400Natural Science Foundation of China 21933010Natural Science Foundation of China 81972916Natural Science Foundation of China 82027805Natural Science Foundation of China 82103054Science and Technology Innovation Foundation of Dalian 2020JJ25CY018
6 · The paper itself

Abstract

Patients who have non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutations are more prone to brain metastasis (BM) and poor prognosis. Previous studies showed that the tumor microenvironment of BM in these patients is immunosuppressed, as indicated by reduced T-cell abundance and activity, although the mechanism of this immunosuppression requires further study. This study shows that reactive astrocytes play a critical role in promoting the immune escape of BM from EGFR-mutated NSCLC by increasing the apoptosis of CD8

Indexed as

AstrocytesB7-H1 AntigenBrain NeoplasmsCarcinoma, Non-Small-Cell LungErbB ReceptorsInterleukin-11Lung NeoplasmsUp-RegulationAnimalsCell Line, TumorDisease Models, AnimalHumansMiceMutationTumor EscapeTumor MicroenvironmentB7-H1 AntigenCD274 protein, humanEGFR protein, humanErbB ReceptorsIL11 protein, humanInterleukin-11astrocytesbrain metastasisepidermal growth factor receptorimmune escapeinterleukin‐11

Identifiers

PMID38696655
PMCPMC11234401

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.